GL1X · GenesisL1 explorer

UniProt P68371

Tubulin beta-4B chain (P68371)

Tubulin beta-4B chain (UniProt P68371): 3 experimental structures and 1 predicted model on GenesisL1, 3 ligands bound, 54 pockets. Binding sites, druggability and experiment against prediction (TM-score) in GL1X.

UniProt
P68371
Protein
Tubulin beta-4B chain
Experimental structures
3
Predicted models
1
Ligands
3
Pockets
54 · 4 records with a druggable one

Structures

4 records of P68371 in the MolNFT archive: 3 experimental, 1 predicted.

EntryTitleMethodChainsLigandsPockets
7UN18-nm repeat of the human sperm tip singlet microtubuleelectron microscopyAB, AD, AF, BA, BD, BF, CB, CD, CF, DB, DD, DF, EB, ED, EF, FD, FF, FH, GD, GF, GH, HD, HF, HH, ID, IF, IH, JD, JF, KD, KF, KH, LB, LD, LF, MB, MD, MFGDP, GTP, MG20 (best 0.85)
7UNG48-nm repeat of the human respiratory doublet microtubuleelectron microscopyAB, AD, AF, AH, AJ, AL, BB, BD, BF, BH, BJ, BL, CB, CD, CF, CH, CJ, CL, DB, DD, DF, DH, DJ, DL, EB, ED, EF, EH, EJ, EL, EN, FB, FD, FF, FH, FJ, FL, FN, GB, GD, GF, GH, GJ, GL, GN, HB, HD, HF, HH, HJ, HL, HN, IB, ID, IF, IH, IJ, IL, IN, JB, JD, JF, JH, JJ, JL, JN, KB, KD, KF, KH, KJ, KL, KN, LB, LD, LF, LH, LJ, LL, LN, MB, MD, MF, MH, MJ, ML, MN, NB, ND, NF, NH, NJ, NL, NN, OB, OD, OF, OH, OJ, OL, ON, PD, PF, PH, PJ, PL, PN, QD, QF, QH, QJ, QL, QN, RD, RF, RH, RJ, RL, RN, SD, SF, SH, SJ, SL, SN, TD, TF, TH, TJ, TL, TN, TP, UD, UF, UH, UJ, UL, UN, UP, VD, VF, VH, VJ, VL, VN, VP, WD, WF, WH, WJ, WL, WN, WPGDP, GTP, MG18 (best 0.88)
8SH7TUBB4B and TUBA1A Heterodimer from Human Respiratory Doublet Microtubuleselectron microscopyBGTP, MG, GDP9 (best 0.84)
P68371AlphaFold monomer V2.0 prediction for tubulin beta-4B chain (P68371)predictedA—7 (best 0.65)

Ligands

  • GDP · Guanosine-5'-diphosphate · in 3 records
  • GTP · Guanosine-5'-triphosphate · in 3 records
  • MG · Magnesium ion · in 3 records

Experiment against prediction

Elsewhere

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.